Cargando…
The synthetic integron: an in vivo genetic shuffling device
As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangemen...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926619/ https://www.ncbi.nlm.nih.gov/pubmed/20534632 http://dx.doi.org/10.1093/nar/gkq511 |
_version_ | 1782185713654038528 |
---|---|
author | Bikard, David Julié-Galau, Stéphane Cambray, Guillaume Mazel, Didier |
author_facet | Bikard, David Julié-Galau, Stéphane Cambray, Guillaume Mazel, Didier |
author_sort | Bikard, David |
collection | PubMed |
description | As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangements of genetic elements from randomized libraries may well be a useful approach for successful engineering. Here, we propose the construction and optimization of metabolic pathways using the inherent gene shuffling activity of a natural bacterial site-specific recombination system, the integron. As a proof of principle, we constructed and optimized a functional tryptophan biosynthetic operon in Escherichia coli. The trpA-E genes along with ‘regulatory’ elements were delivered as individual recombination cassettes in a synthetic integron platform. Integrase-mediated recombination generated thousands of genetic combinations overnight. We were able to isolate a large number of arrangements displaying varying fitness and tryptophan production capacities. Several assemblages required as many as six recombination events and produced as much as 11-fold more tryptophan than the natural gene order in the same context. |
format | Text |
id | pubmed-2926619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29266192010-08-30 The synthetic integron: an in vivo genetic shuffling device Bikard, David Julié-Galau, Stéphane Cambray, Guillaume Mazel, Didier Nucleic Acids Res Methods Online As the field of synthetic biology expands, strategies and tools for the rapid construction of new biochemical pathways will become increasingly valuable. Purely rational design of complex biological pathways is inherently limited by the current state of our knowledge. Selection of optimal arrangements of genetic elements from randomized libraries may well be a useful approach for successful engineering. Here, we propose the construction and optimization of metabolic pathways using the inherent gene shuffling activity of a natural bacterial site-specific recombination system, the integron. As a proof of principle, we constructed and optimized a functional tryptophan biosynthetic operon in Escherichia coli. The trpA-E genes along with ‘regulatory’ elements were delivered as individual recombination cassettes in a synthetic integron platform. Integrase-mediated recombination generated thousands of genetic combinations overnight. We were able to isolate a large number of arrangements displaying varying fitness and tryptophan production capacities. Several assemblages required as many as six recombination events and produced as much as 11-fold more tryptophan than the natural gene order in the same context. Oxford University Press 2010-08 2010-06-09 /pmc/articles/PMC2926619/ /pubmed/20534632 http://dx.doi.org/10.1093/nar/gkq511 Text en © The Author(s) 2010. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methods Online Bikard, David Julié-Galau, Stéphane Cambray, Guillaume Mazel, Didier The synthetic integron: an in vivo genetic shuffling device |
title | The synthetic integron: an in vivo genetic shuffling device |
title_full | The synthetic integron: an in vivo genetic shuffling device |
title_fullStr | The synthetic integron: an in vivo genetic shuffling device |
title_full_unstemmed | The synthetic integron: an in vivo genetic shuffling device |
title_short | The synthetic integron: an in vivo genetic shuffling device |
title_sort | synthetic integron: an in vivo genetic shuffling device |
topic | Methods Online |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926619/ https://www.ncbi.nlm.nih.gov/pubmed/20534632 http://dx.doi.org/10.1093/nar/gkq511 |
work_keys_str_mv | AT bikarddavid thesyntheticintegronaninvivogeneticshufflingdevice AT juliegalaustephane thesyntheticintegronaninvivogeneticshufflingdevice AT cambrayguillaume thesyntheticintegronaninvivogeneticshufflingdevice AT mazeldidier thesyntheticintegronaninvivogeneticshufflingdevice AT bikarddavid syntheticintegronaninvivogeneticshufflingdevice AT juliegalaustephane syntheticintegronaninvivogeneticshufflingdevice AT cambrayguillaume syntheticintegronaninvivogeneticshufflingdevice AT mazeldidier syntheticintegronaninvivogeneticshufflingdevice |